Curis, Inc. (CRIS)
1.15
+0.07
(+6.48%)
USD |
NASDAQ |
Feb 13, 16:00
1.12
-0.03
(-2.61%)
After-Hours: 20:00
Curis EPS Diluted (Quarterly) : -0.4929 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
| Enzon Pharmaceuticals, Inc. | -0.0183 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.729M |
| Revenue (Quarterly) | 3.176M |
| Total Expenses (Quarterly) | 10.90M |
| Enterprise Value | 36.42M |
| Gross Profit Margin (Quarterly) | 98.52% |
| Profit Margin (Quarterly) | -243.4% |
| Earnings Yield | -319.7% |
| Normalized Earnings Yield | -319.74 |